Dr. Cripe's clinical interests include gene and viral therapies for solid tumors in children, including brain tumors, neuroblastoma, and bone and soft tissue sarcomas. His current research focuses on developing and testing new, targeted therapies for pediatric solid tumors and translating those findings into clinical studies. He was among the first in the country to launch clinical trials of attenuated oncolytic viruses in children. Dr. Cripe completed his degrees in medicine and philosophy and received his pediatric residency training at the University of Iowa. He was a fellow in pediatric hematology/oncology at the Children's Hospital and the Dana-Farber Cancer Institute in Boston, and at the Children's Hospital and University of Colorado Health Sciences Center in Denver. He has been on faculty at the University of Wisconsin-Madison and at Cincinnati Children's Hospital Medical Center, where he was the founding director of the comprehensive sarcoma program and the medical director of the Translational Research Trials Office. Dr. Cripe is voted among the Best Doctors in America.
Date of Appointment at Nationwide Children’s Hospital: 01/27/2012
- Pediatric Hematology Oncology
|Fellowship||The Children's Hospital - University of Colorado||Date Completed: 06/30/1995|
|Fellowship||Boston Children's Hospital||Date Completed: 06/30/1993|
|Residency||University of Iowa Hospitals and Clinics||Date Completed: 07/01/1992|
|Medical School||University of Iowa||Date Completed: 05/06/1989|